Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Wang, Yingjun  [Clear All Filters]
2014
Yao Y, Zhai Z, Wang Y. Evaluation of Insulin Medium or Chondrogenic Medium on Proliferation and Chondrogenesis of ATDC5 Cells. Biomed Res Int. 2014;2014:569241.
2015
Wang Y, Zhu G, Li N, Song J, Wang L, Shi X. Small molecules and their controlled release that induce the osteogenic/chondrogenic commitment of stem cells. Biotechnol Adv. 2015.
2016
Gao M, Chen J, Lin G, Li S, Wang L, Qin A, Zhao Z, Ren L, Wang Y, Tang BZhong. Long-Term Tracking of the Osteogenic Differentiation of Mouse BMSCs by Aggregation-Induced Emission Nanoparticles. ACS Appl Mater Interfaces. 2016.
Hao L, Fu X, Li T, Zhao N, Shi X, Cui F, Du C, Wang Y. Surface chemistry from wettability and charge for the control of mesenchymal stem cell fate through self-assembled monolayers. Colloids Surf B Biointerfaces. 2016;148:549-556.
2019
Li M, Fu X, Gao H, Ji Y, Li J, Wang Y. Regulation of an osteon-like concentric microgrooved surface on osteogenesis and osteoclastogenesis. Biomaterials. 2019;216:119269.
2020
Wan S, Wu Q, Ji Y, Fu X, Wang Y. Promotion of the immunomodulatory properties and osteogenic differentiation of adipose-derived mesenchymal stem cells in vitro by lentivirus-mediated miR-146a sponge expression. J Tissue Eng Regen Med. 2020.
2023
Yang Q, Miao Y, Luo J, Chen Y, Wang Y. Amyloid Fibril and Clay Nanosheet Dual-Nanoengineered DNA Dynamic Hydrogel for Vascularized Bone Regeneration. ACS Nano. 2023.
Al-Juhaishi T, Wang Y, Milton DR, Xu-Monette ZY, Jabbour E, Daher M, Im JS, Bashir Q, Iyer SP, Marin D, et al. Clinical relevance of MYC/BCL2 expression and cell of origin in patients with diffuse large b-cell lymphoma treated with autologous transplant. Bone Marrow Transplant. 2023.
Zhuang C, Zhu G, Wang Y, Wang L, Shi X, Mao C. A Facile Crystallization Strategy To Turn Calcium Bisphosphonates Into Novel Osteogenesis-Inducing Biomaterials. Adv Healthc Mater. 2023:e2203004.
2024
Dong J, Chen F, Yao Y, Wu C, Ye S, Ma Z, Yuan H, Shao D, Wang L, Wang Y. Bioactive mesoporous silica nanoparticle-functionalized titanium implants with controllable antimicrobial peptide release potentiate the regulation of inflammation and osseointegration. Biomaterials. 2024;305:122465.